Takeda’s two-dose QDENGA vaccine, approved by the Drug Controller General of India, can be administered without prior dengue screening and is designed to protect against all four dengue virus serotypes
Takeda’s two-dose QDENGA vaccine, approved by the Drug Controller General of India, can be administered without prior dengue screening and is designed to protect against all four dengue virus serotypes
<iframe src="https://hindustansphere.com/embed/cluster/4a7fd97ae12a3489d40e2273e36d086928cfa776" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="India approves first dengue vaccine for individuals aged 4 to 60 years"></iframe>
Takeda’s two-dose QDENGA vaccine, approved by the Drug Controller General of India, can be administered without prior dengue screening and is designed to protect against all four dengue virus serotypes
